Session Information
-
WCLC 2018
19th World Conference on Lung Cancer
Conference Program for the 19th World Conference on Lung Cancer in Toronto, Canada
Download PDF of the Abstract Book: Click Here.
Presentation Date(s):- Sept 23 - 26, 2018
- Total Presentations: 2391
September 23 Sun
Sep 23 Monday
September 24 Mon
Sep 24 Tuesday
September 25 Tue
Sep 25 Wednesday
September 26 Wed
Sep 26
-
+
MA06 - PDL1, TMB and DNA Repair
- 13:30 - 15:00
- 9/24/2018
- Location: Room 206 AC
- Type: Mini Oral Abstract Session
- Track: Biology
-
+
MA06.11 - Distinct Origins of Lymphatic and Brain Metastasis in Lung Cancer
14:40 - 14:45 | Presenter: Tao Jiang | Author(s): Yan Yan, Caicun Zhou
- Abstract
Loading...
-
+
MA09 - Lung Cancer Surgical and Molecular Pathology
- 15:15 - 16:45
- 9/24/2018
- Location: Room 202 BD
- Type: Mini Oral Abstract Session
- Track: Pathology
-
+
MA09.11 - Genomic Landscape and its Correlation with TMB, CD8 TILs and PD-L1 Expression in Chinese Lung Squamous Cell Carcinoma
16:25 - 16:30 | Presenter: Tao Jiang | Author(s): Jinpeng Shi, Chunyan Wu, Henghui Zhang, Caicun Zhou
- Abstract
Loading...
-
+
OA07 - Oligometastasis: What Should Be the State-Of-The-Art?
- 15:15 - 16:45
- 9/24/2018
- Location: Room 107
- Type: Oral Abstract Session
- Track: Oligometastatic NSCLC
-
+
OA07.03 - Addition of Local Therapy to EGFR TKI Showed Survival Benefit in EGFR-Mutant NSCLC pts with Oligometastatic or Oligoprogressive Liver Metastases
15:35 - 15:45 | Presenter: Tao Jiang | Author(s): Caicun Zhou, Huijuan Wang, Qian Chu
- Abstract
Loading...
-
+
P1.13 - Targeted Therapy (Not CME Accredited Session)
- 16:45 - 18:00
- 9/24/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P1.13-26 - First-Line Continual EGFR-TKI Plus LAT Demonstrated Survival Benefit in Egfr-Mutant Nsclc Patients with Oligoprogressive Disease
16:45 - 18:00 | Presenter: Qinghua Xu | Author(s): Hui Liu, Tao Jiang, Shengxiang Ren, Caicun Zhou
- Abstract
Loading...
-
+
MA11 - Biomarkers of IO Response
- 10:30 - 12:00
- 9/25/2018
- Location: Room 203 BD
- Type: Mini Oral Abstract Session
- Track: Immunooncology
-
+
MA11.11 - Discrepancy of Tumor Neoantigen Burden Between Primary Lesions and Matched Metastases in Lung Cancer
11:40 - 11:45 | Presenter: Tao Jiang | Author(s): Caicun Zhou
- Abstract
Loading...
-
+
MA15 - Colliding Approaches - EGFR and Immunotherapy
- 13:30 - 15:00
- 9/25/2018
- Location: Room 107
- Type: Mini Oral Abstract Session
- Track: Targeted Therapy
-
+
MA15.09 - Dynamic Monitoring and Predictive Value of Circulating Tumor Cells in EGFR Mutant Advanced NSCLC Patients Treated with First-Line EGFR-TKIs
14:30 - 14:35 | Presenter: Chunxia Su | Author(s): Tao Jiang, Jing Zhao, Xuefei Li, Caicun Zhou
- Abstract
Loading... -
+
MA15.10 - Loss of T790M Mutation is Associated with Early Progression to Osimertinib in Chinese Advanced NSCLC Patients Harboring EGFR T790M
14:35 - 14:40 | Presenter: Sha Zhao | Author(s): Tao Jiang, Xuefei Li, Chao Zhao, Chunxia Su, Shengxiang Ren, Caicun Zhou
- Abstract
Loading...
-
+
P3.04 - Immunooncology (Not CME Accredited Session)
- 12:00 - 13:30
- 9/26/2018
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track:
-
+
P3.04-21 - Antibiotics Attenuate the Clinical Benefit of Anti-PD-(L)1 Immunotherapies in Chinese Patients with Advanced Non-Small Cell Lung Cancer
12:00 - 13:30 | Presenter: Sha Zhao | Author(s): Yijun Jia, Tao Jiang, Xuefei Li, Wei Li, Guanghui Gao, Chao Zhao, Yayi He, Xiaoxia Chen, Chunxia Su, Shengxiang Ren, Caicun Zhou
- Abstract
Loading...
-
+
MA26 - New Therapies and Emerging Data in ALK, EGFR and ROS1
- 13:30 - 15:00
- 9/26/2018
- Location: Room 201 BD
- Type: Mini Oral Abstract Session
- Track: Targeted Therapy
-
+
MA26.05 - Comprehensive Analysis of Treatment Response and Progression Pattern in Chinese Patients with Different ALK Fusion-Variants
14:00 - 14:05 | Presenter: Meng Qiao | Author(s): Chao Zhao, Xuefei Li, Tao Jiang, Fengying Wu, Xiaoxia Chen, Chunxia Su, Caicun Zhou
- Abstract
Loading...
-
+
MA27 - Novel Drugs and PDX Models
- 13:30 - 15:00
- 9/26/2018
- Location: Room 206 BD
- Type: Mini Oral Abstract Session
- Track: Targeted Therapy
